Loading…
TXMD
TherapeuticsMD, Inc.
NASDAQ· Healthcare· Drug Manufacturers - Specialty & Generic· CUSIP 88338N206
$2.16+2.86%Price as of Sep 22, 22:39 UTC · updated once a day, after the close
Key metrics
- Market cap
- $25M
- P/E
- —
- Forward P/E
- 6.2x
- P/B
- 0.9x
- Dividend yield
- —
- Payout
- —
- EPS
- -$0.03
- ROE
- -1.08%
- Profit margin
- -6.64%
- Revenue growth
- -8.70%
- Beta
- 0.65
- 52-week high
- $2.95
- 52-week low
- $0.99
History
How the company evolved, year by year. Revenue and debt come from the annual reports — for most companies, the 10-K filings with the SEC since 2009; dividends from the payments themselves.
The bars are a balance on the closing date; the lines are what happened during the year. Revenue above equity is ordinary, not an anomaly — it means the company turns its capital over more than once a year.
Investors holding this
Major managers that reported this stock in their latest 13F.
Price over time
▼ -94.4% over 5Y.
today you would have $55.41▼ -94.5%
Dividends reinvested, splits accounted for. Past prices say what happened, not what will.
Indicators, year by year
The last 16 closed years. Each multiple uses that year’s closing price and that year’s reported numbers — not today’s. The range is set by the annual reports on record.
| Indicator | Median | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Year-end price | $1.63 | $0.86 | $2.25 | $5.59 | $18.00 | $60.50 | $121.00 | $190.50 | $302.00 | $288.50 | $518.50 | $222.50 | $260.50 | $155.00 | $75.00 | $150.00 | |
| P/E | — |
Others in the same sector
Companies of similar size in Healthcare, for comparison. The columns are the same ones above, in the same order.
| Stock | Price | P/E | P/B | Dividend yield | ROE | Market cap |
|---|---|---|---|---|---|---|
| EVAXEvaxion A/S | $3.01 | — | 2.4x | — | -109.86% | $25.1M |
| DYAIDyadic International Inc | $0.61 | — | — | — | — | $24.6M |
| TVRDTvardi Therapeutics, Inc. | $1.82 | — | 1.2x | — | -126.19% | $24.28M |
| ATOSAtossa Therapeutics Inc | $2.58 |
About the company
TherapeuticsMD, Inc. operates as a pharmaceutical royalty company in the United States and internationally. Its products portfolio includes IMVEXXY for the treatment of moderate-to-severe dyspareunia, a symptom of vulvar and vaginal atrophy due to menopause; BIJUVA to treat moderate-to-severe vasomotor symptoms due to menopause in women with a uterus; and ANNOVERA, a ring-shaped contraceptive vaginal system. The company also offers prescription prenatal vitamin products under the BocaGreenMD and vitaMedMD brand names. It has a license agreement with Mayne Pharma Group Limited. The company sells its products through wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida.
- 1
- Boca Raton, United States
Company description provided by Yahoo Finance.